Entecavir-d2

Entecavir-d2 is intended for use as an internal standard for the quantification of entecavir (Cay-36926, Cay-13831) by GC- or LC-MS. Entecavir is an antiviral nucleoside analog of 2'-deoxyguanosine (Cay-9002864) and inhibitor of hepatitis B virus (HBV) reverse transcriptase (IC50 = 0.5 nM). It undergoes phosphorylation by cellular kinases to its active form, entecavir triphosphate. Entecavir reduces virion DNA in the culture supernatant of HepG2 2.2.15 cells infected with hepatitis B virus (HBV, EC50 = 3.75 nM). It reduces serum and hepatic levels of viral DNA in a duckling model of HBV infection when administered at a dose of 1 mg/kg. Formulations containing entecavir have been used in the treatment of chronic HBV infection.Formal Name: 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one. Molecular Formula: C12H13D2N5O3. Formula Weight: 279.3. Purity: >99% deuterated forms (d1-d2). Formulation: (Request formulation change), A solid. Solubility: DMSO: Soluble, Methanol: Soluble, Water: Soluble. SMILES: O=C(N=C(N1)N)C2=C1N([C@@]3([H])C[C@H](O)[C@@H](CO)/C3=C([2H])/[2H])C=N2. InChi Code: InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1/i1D2. InChi Key: QDGZDCVAUDNJFG-FIIIVWQOSA-N.